By Hannah Bloch (The Wall Street Journal) – I love it when people tell me I can’t do something,” says Jim Olson. A pediatric oncologist at Seattle’s Fred Hutchinson Cancer Research Center and the founder of two biotech companies, Dr. Olson specializes in brain cancer.
The Pershing Square Sohn Cancer Research Alliance announced the 2014 Prize winners. Below is a list of all of our media coverage for the announcement.
By Denise Grade ( The New York Times) – Doctors have taken an important step toward a long-sought goal: harnessing a person’s own immune system to fight cancer.
Award encourages young investigators to take risks in search of a cure Cold Spring Harbor, NY – The Pershing Square Sohn Cancer Research Alliance is honoring Lloyd Trotman, Associate Professor at Cold Spring Harbor Laboratory (CSHL). Trotman will receive one of six prizes for Young Investigators in Cancer Research, which seeks to fuel innovative scientific … Continued
(The City College of New York) – Associate Professor of Biomedical Engineering Sihong Wang is one of six young scientists from the New York City area to receive the inaugural Pershing Square Sohn Prize for Young Investigators in Cancer Research.
Through a generous commitment of $25 million from the Pershing Square Foundation, the Pershing Square Sohn Cancer Research Alliance has created a prestigious program that will award $1.2 million in its first year to exceptional young scientists in New York City with innovative ideas in the field of cancer research.
Bill Ackman invests in young research scientists. Here are the first six to benefit. By Barbara Benson (Crain’s Business New York) – Home to some of the top medical institutions in the country, New York City attracts millions of dollars in annual federal research funding.
The Pershing Square Sohn Cancer Research Alliance today announced the winners of the inaugural Pershing Square Sohn Prize for Young Investigators in Cancer Research. Awarded to six New York City-based scientists at the Sohn Investment Conference, the Prize winners will each receive $200,000 per year for up to three years to enable them to pursue cutting-edge research at a stage when traditional funding is lacking.
By Amanda Gordon (Bloomberg Business Week) – Three days after announcing a $17 million donation to Harvard, activist investor Bill Ackman disappeared into a roomful of scientists to decide where his and his wife’s next gift should go.
(PNAS Journal) – The long-held but erroneous assumption of never-ending rapid growth in biomedical science has created an unsustainable hypercompetitive system that is discouraging even the most outstanding prospective students from entering our profession—and making it difficult for seasoned investigators to produce their best work. This is a recipe for long-term decline, and the problems … Continued